Javascript must be enabled to continue!
The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications
View through CrossRef
Background
Myotonic dystrophy (MD1) is a hereditary autosomal dominant disease with variable penetrance. Cardiac conduction disturbances are frequent and may be responsible for sudden death, but its progression was heretofore unknown.
Aims
The aim of the study was to analyse the natural history of infrahissian conduction time in patients with a normal first electrophysiological test, and to identify the predictive value of the clinical and ECG factors accompanying an alteration of infrahissian conduction.
Methods
Among 127 consecutive screened MD patients, 25 were enrolled and underwent a second electrophysiological testing. The second electrophysiological test was carried out on patients showing new symptoms, new atrioventricular conduction disturbances on ECG, or significant modifications of signal-averaged (SA)-ECG, and on asymptomatic patients with a follow-up of at least 60 months since the first electrophysiological test.
Results
Among the 25 patients, four had new clinical symptoms, four others developed new atrioventricular conduction abnormalities on ECG and six had significant modifications of the SA-ECG. The mean His-ventricle (HV) interval increased significantly between the two electrophysiological studies (initial HV interval 52.1 ms±1.6 ms, final HV interval 61.4 ms±2.2 ms, p<0.005), with a mean increase of 1.2 ms/year. The five patients with HV interval of 70 ms or greater were implanted with a prophylactic dual-chamber pacemaker. Modifications of resting ECG and SA-ECG were strongly associated with HV interval prolongation.
Conclusion
In patients with a normal initial electrophysiological study, modifications on the resting ECG and/or SA-ECG, on annual check-up, were associated with an alteration of infrahissian conduction.
Title: The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications
Description:
Background
Myotonic dystrophy (MD1) is a hereditary autosomal dominant disease with variable penetrance.
Cardiac conduction disturbances are frequent and may be responsible for sudden death, but its progression was heretofore unknown.
Aims
The aim of the study was to analyse the natural history of infrahissian conduction time in patients with a normal first electrophysiological test, and to identify the predictive value of the clinical and ECG factors accompanying an alteration of infrahissian conduction.
Methods
Among 127 consecutive screened MD patients, 25 were enrolled and underwent a second electrophysiological testing.
The second electrophysiological test was carried out on patients showing new symptoms, new atrioventricular conduction disturbances on ECG, or significant modifications of signal-averaged (SA)-ECG, and on asymptomatic patients with a follow-up of at least 60 months since the first electrophysiological test.
Results
Among the 25 patients, four had new clinical symptoms, four others developed new atrioventricular conduction abnormalities on ECG and six had significant modifications of the SA-ECG.
The mean His-ventricle (HV) interval increased significantly between the two electrophysiological studies (initial HV interval 52.
1 ms±1.
6 ms, final HV interval 61.
4 ms±2.
2 ms, p<0.
005), with a mean increase of 1.
2 ms/year.
The five patients with HV interval of 70 ms or greater were implanted with a prophylactic dual-chamber pacemaker.
Modifications of resting ECG and SA-ECG were strongly associated with HV interval prolongation.
Conclusion
In patients with a normal initial electrophysiological study, modifications on the resting ECG and/or SA-ECG, on annual check-up, were associated with an alteration of infrahissian conduction.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Pattern retinal dystrophy in a case of myotonic dystrophy
Pattern retinal dystrophy in a case of myotonic dystrophy
Myotonic dystrophy is an autosomal dominant disease which can present with various ocular manifestations. A case of myotonic dystrophy presented with limited visual recovery postca...
Myotonic Dystrophies: A Genetic Overview
Myotonic Dystrophies: A Genetic Overview
Myotonic dystrophies (DM) are the most common muscular dystrophies in adults, which can affect other non-skeletal muscle organs such as the heart, brain and gastrointestinal system...
Therapeutic trials and future advances
Therapeutic trials and future advances
Abstract
Recent discoveries of the gene defects responsible for myotonic dystrophy type I (DM1) (Brook et al. 1992; Fu et al. 1992; Mahadevan et al 1992) and myotoni...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Ma...
Novel genetic causes of childhood cancer predisposition
Novel genetic causes of childhood cancer predisposition
<p dir="ltr">Childhood cancer predisposition syndromes (CPS) refer to rare diseases increasing the risk of developing pediatric cancer. Genomic studies have estimated that ab...
Novel genetic causes of childhood cancer predisposition
Novel genetic causes of childhood cancer predisposition
<p dir="ltr">Childhood cancer predisposition syndromes (CPS) refer to rare diseases increasing the risk of developing pediatric cancer. Genomic studies have estimated that ab...
Novel genetic causes of childhood cancer predisposition
Novel genetic causes of childhood cancer predisposition
<p dir="ltr">Childhood cancer predisposition syndromes (CPS) refer to rare diseases increasing the risk of developing pediatric cancer. Genomic studies have estimated that ab...

